Early research (Phase 1)Ended earlyNCT03277482
What this trial is testing
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
Who this might be right for
Recurrent Gynecological CancerMetastatic Cervical CancerMetastatic Ovarian Cancer+8 more
Dana-Farber Cancer Institute 16